Verona Pharma (VRNA) Stock Highlights

38.85 | +2%

2024-11-21 02:23:11

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Statistics

Range Today

37.61 39.33

Volume Today 1.16M

Range 1 Year

11.39 40.13

Volume 1 Year 224.49M

Range 3 Year

3.41 40.13

Volume 3 Year 453.19M

Range 10 Year

2.01 40.13

Volume 10 Year 612.81M

Highlights

Market Capitalization 3.16B (mid)

Floating Shares 387.21M

Current Price 38.85

Price To Earnings -19.06

Price To Book 12.45

Earnings Per Share -2.02

Payout Ratio 0%

Performance

Latest +2%

1 Month +12.41%

3 Months +43.2%

6 Months +197.7%

1 Year +166.83%

3 Years +642.83%

5 Years +811.97%

10 Years +187.78%

Benchmarks

Market Capitalization

101 / 368

Gross Profits

146 / 278

Total Revenue

253 / 300

Total Rank

56 / 368

Free Cashflow

181 / 352

Performance 5 years

12 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.